Product Details
PMS-Fluoxetine
Fluoxetine HCl60 mg
Capsule
DIN/PIN/NPN
02464659
Manufacturer
Pharmascience Inc.
Formulary Listing Date
2021-02-26
Unit Price
0.9933
Amount MOH Pays
0.9933
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Fluoxetine HCl: Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.
ATC Code
N06AB03